(Q37376917)

English

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

scientific article published on 28 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

chemoradiotherapy

0 references

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Akiko Kuwahara

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Motohiro Yamamori

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kohshi Nishiguchi

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tatsuya Okuno

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Naoko Chayahara

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ikuya Miki

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Takao Tamura

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tsubasa Inokuma

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Yoshiji Takemoto

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tsutomu Nakamura

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kazusaburo Kataoka

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Toshiyuki Sakaeda

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

28 September 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

International Journal of Medical Sciences

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

305-311

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Evaluation of combined nedaplatin and docetaxel therapy for human head and neck cancer in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

6 September 2017

Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

28 September 2017

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

26 June 2018

VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

2 September 2018

Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

2 September 2018

Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

2 September 2018

Circadian variability of pharmacokinetics of 5-fluorouracil and CLOCK T3111C genetic polymorphism in patients with esophageal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

2 September 2018

Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

2 September 2018

Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757668

2 September 2018

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19834547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7150/IJMS.6.305

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37376917&oldid=1702811259"